HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Baoshan Cao Selected Research

Baoshan Cao Research Topics

Disease

11Neoplasms (Cancer)
10/2022 - 08/2012
7Adenocarcinoma of Lung
03/2022 - 02/2014
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 08/2012
4Lung Neoplasms (Lung Cancer)
07/2019 - 08/2012
3Neoplasm Metastasis (Metastasis)
12/2021 - 10/2012
2Pleural Effusion (Pleural Effusions)
03/2022 - 03/2019
1COVID-19
10/2022
1Mucositis
03/2022
1Diarrhea
03/2022
1Neutropenia
03/2022
1Vomiting
03/2022
1Colorectal Neoplasms (Colorectal Cancer)
03/2022
1Pain (Aches)
01/2022
1Esophageal Neoplasms (Esophageal Cancer)
01/2022
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2021
1Necrosis
12/2020
1Ischemia
12/2020
1Breast Neoplasms (Breast Cancer)
12/2020
1Hepatitis
01/2020
1Radiation Injuries (Radiation Sickness)
07/2019
1Hypoalbuminemia
07/2019
1Venous Thromboembolism
07/2019
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2019
1Carcinogenesis
03/2014

Drug/Important Bio-Agent (IBA)

8ErbB Receptors (EGF Receptor)IBA
03/2022 - 02/2014
5Tyrosine Kinase InhibitorsIBA
12/2021 - 02/2014
5Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2012
3Biomarkers (Surrogate Marker)IBA
06/2018 - 08/2012
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
2Pharmaceutical PreparationsIBA
01/2021 - 01/2017
2Anaplastic Lymphoma KinaseIBA
03/2019 - 03/2014
2Biological ProductsIBA
01/2017 - 08/2012
1Irinotecan (Camptosar)FDA LinkGeneric
03/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1Opioid Analgesics (Opioids)IBA
01/2022
1Sorafenib (BAY 43-9006)FDA Link
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Simvastatin (Zocor)FDA LinkGeneric
12/2020
1bicyclolIBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
1B7-H1 AntigenIBA
01/2020
1pembrolizumabIBA
01/2020
1Programmed Cell Death 1 ReceptorIBA
01/2020
1MethylprednisoloneFDA LinkGeneric
01/2020
1Serum AlbuminIBA
07/2019
1AlbuminsIBA
07/2019
1fibrin fragment D (D-dimer)IBA
07/2019
1Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2019
1Indicators and Reagents (Reagents)IBA
06/2018
1apatinibIBA
10/2017
1Epithelial Cell Adhesion MoleculeIBA
09/2017
1GemcitabineFDA Link
02/2015
1Monoclonal AntibodiesIBA
02/2015
1Pemetrexed (MTA)FDA Link
02/2015
1Paclitaxel (Taxol)FDA LinkGeneric
02/2015
1taxaneIBA
02/2015
1Vinorelbine (Navelbine)FDA LinkGeneric
02/2015
1Immunoglobulin G (IgG)IBA
02/2015
1nimotuzumabIBA
02/2015
1PlatinumIBA
10/2012
1EndostatinsIBA
08/2012

Therapy/Procedure

6Drug Therapy (Chemotherapy)
03/2022 - 10/2012
3Therapeutics
01/2021 - 10/2017
2Radiotherapy
12/2021 - 01/2013
1Hand Hygiene
10/2022
1Treatment Delay
10/2022
1Immunotherapy
01/2020